Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/03/2013US20130259824 Treatment for Ischemic Stroke
10/03/2013US20130259809 Use of polysaccharides from radix isatidis in manufacture of medicaments against influenza virus
10/03/2013US20130259800 Compositions and methods for cancer treatment
10/03/2013CA2877555A1 Cinacalcet and neuroblastic tumours
10/02/2013EP2644700A1 Compositions and methods for modulation of SMN2 splicing
10/02/2013EP2644624A1 6-deoxy-6-thioether-amino acid cyclodextrin derivatives and preparation method thereof
10/02/2013EP2644614A2 Solid state forms of 5-azacytidine and processes for preparation thereof
10/02/2013EP2644601A1 Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereof
10/02/2013EP2644600A1 Heterocyclic aspartyl protease inhibitors
10/02/2013EP2644594A1 Cancer Cell Targeting Using Nanoparticles
10/02/2013EP2644213A1 Drug-containing bioabsorbable fibers and implants
10/02/2013EP2644199A1 Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents
10/02/2013EP2644198A1 Antianxiety and sleep disorder improving use of albiflorin or metabolite thereof in
10/02/2013EP2644197A1 Novel Pharmaceutical Compositions of Entecavir
10/02/2013EP2644196A1 Pharmaceutical compositions of Entecavir
10/02/2013EP2644195A1 Immunosuppressant Compounds and Compositions
10/02/2013EP2644194A2 Combinations of an anti-HER2 antibody-drug conjugate and docetaxel
10/02/2013EP2644192A1 Cancer Cell Targeting Using Nanoparticles
10/02/2013EP2644190A1 Formulation for hormone therapy
10/02/2013EP2644041A1 Clear liquid carotenoid formulations and clear beverages containing them
10/02/2013EP2644040A1 Condiments with rebaudioside A and erythritol
10/02/2013EP2643463A2 Treatment of nanog related diseases by inhibition of natural antisense transcript to nanog
10/02/2013EP2643462A1 Inhibitors of sp140 and their use in therapy
10/02/2013EP2643372A2 Stealth polymeric particles for delivery of bioactive or diagnostic agents
10/02/2013EP2643336A1 Oligosaccharide mixture and food product comprising this mixture, especially infant formula
10/02/2013EP2643333A2 Novel phosphonic acids as s1p receptor modulators
10/02/2013EP2643327A1 Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
10/02/2013EP2643325A1 Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use
10/02/2013EP2643324A1 Antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]-benzodiazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with phenyl derivatives
10/02/2013EP2643323A1 Compounds for treating respiratory syncytial virus infections
10/02/2013EP2643322A1 Salts and crystalline forms of an apoptosis-inducing agent
10/02/2013EP2643321A1 Imidazo [1,2-b]pyridazine and imidazo [4,5-b]pyridine derivatives as jak inhibitors
10/02/2013EP2643320A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
10/02/2013EP2643319A1 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
10/02/2013EP2643318A1 Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy
10/02/2013EP2643317A1 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
10/02/2013EP2643315A1 BENZOXAZEPINES AS INHIBITORS OF P13K/mTOR AND METHODS OF THEIR USE AND MANUFACTURE
10/02/2013EP2643314A1 Novel salts and polymorphic forms of afatinib
10/02/2013EP2643311A1 Bicyclic gpr119 modulators
10/02/2013EP2643310A1 4- (5-cyano-pyrazol-1-yl) -piperidine derivatives as gpr 119 modulators
10/02/2013EP2643308A1 Process for the preparation of taurolidine and its intermediates thereof
10/02/2013EP2643307A1 Nitrobenzothiazole derivatives and use thereof for treating tuberculosis
10/02/2013EP2643305A1 Multicomponent system of rosuvastatin calcium salt and sorbitol
10/02/2013EP2643303A1 Modulators of s1p receptors
10/02/2013EP2643301A1 Technetium-99m complex as a tool for the in vivo diagnosis of cancerous tumours
10/02/2013EP2643299A1 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions
10/02/2013EP2643298A1 Substituted cyclopentyl - azines as casr- active compounds
10/02/2013EP2643297A1 Indole derivatives as modulators of s1p receptors
10/02/2013EP2643295A1 Glycine derivatives and their use as muscarinic receptor antagonists
10/02/2013EP2643292A1 Calcium-sensing receptor-active compounds
10/02/2013EP2643290A1 Calcium-sensing receptor-active compounds
10/02/2013EP2643022A1 Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin
10/02/2013EP2643020A1 A drug delivery device
10/02/2013EP2643010A2 Biologically active complex and its preparation
10/02/2013EP2643007A2 Pharmaceutical composition comprising extract of lonicera japonica for prevention and treatment of gastroesophageal reflux disease
10/02/2013EP2643006A1 Oligosaccharide composition for treating acute respiratory tract infections
10/02/2013EP2643005A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
10/02/2013EP2643004A1 Oligosaccharide composition for treating skin diseases
10/02/2013EP2643003A1 Vaginal composition based on alkyl polyglucosides
10/02/2013EP2643002A1 Pharmaceutical formulations containing corticosteroids for topical administration
10/02/2013EP2643001A1 Method of treating cancer
10/02/2013EP2643000A2 Therapeutic piperazines
10/02/2013EP2642999A1 Methods of treatment using selective bcl-2 inhibitors
10/02/2013EP2642998A2 A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
10/02/2013EP2642997A1 Nitric oxide donors in therapy of nitric oxide deficiency-induced disturbances of cerebral microcirculation
10/02/2013EP2642996A2 Pharmaceutical compositions
10/02/2013EP2642995A2 Process for preparation of triclabendazole
10/02/2013EP2642994A2 Use of hematopoietic growth factor mimetics
10/02/2013EP2642993A1 Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
10/02/2013EP2642992A1 Compounds and their use
10/02/2013EP2642991A1 Therapeutical method for the treatment of the leber optic
10/02/2013EP2642990A1 Therapeutic use of compounds
10/02/2013EP2642989A1 Methods of treating eye diseases associated with inflammation and vascular proliferation
10/02/2013EP2642988A1 Method and composition for weight-gain management
10/02/2013EP2642987A1 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
10/02/2013EP2642986A2 Methods and compositions to eliminate chronic lymphocytic leukemia and other hematologic malignant cells in stromal microenvironment for cancer therapy
10/02/2013EP2642982A2 Stable cannabinoid compositions and methods for making and storing them
10/02/2013EP2642981A1 Solid dosage forms of oleyl phosphocholine
10/02/2013EP2642979A1 A pharmaceutical composition
10/02/2013EP2642978A2 Immunomodulatory compositions comprising hydralazine for the treatment of gastrointestinal disorders
10/02/2013EP2642876A1 Oligosaccharide mixture and food product comprising this mixture, especially infant formula
10/02/2013EP2642872A1 Protective hydrocolloid for active ingredients
10/02/2013EP2642859A2 Method of treating neurological conditions with extract of nerium species or thevetia species
10/02/2013EP2642856A1 Integrin-linked kinase inhibitors
10/02/2013EP2642855A1 Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium
10/02/2013EP2484365B1 Compositions and method for treatment of neovascular diseases
10/02/2013EP2295423B1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
10/02/2013CN203220605U Quick-acting tumor pain relieving bag
10/02/2013CN203220604U Valnemulin long-acting granular pill
10/02/2013CN103339141A C-28 amines of c-3 modified betulinic acid derivatives as hiv maturation inhibitors
10/02/2013CN103339139A 7-deazapurine modulators of histone methyltransferase, and methods of use thereof
10/02/2013CN103339138A 选择性糖苷酶抑制剂及其用途 Selective glycosidase inhibitors and their uses
10/02/2013CN103339136A Uridine di- or tri-phosphate derivatives and uses thereof
10/02/2013CN103339134A Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
10/02/2013CN103339132A Novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredi
10/02/2013CN103339131A Pharmaceutical composition comprising pyridone derivatives
10/02/2013CN103339130A Methods of making hiv attachment inhibitor prodrug compound and intermediates
10/02/2013CN103339129A Derivatives of azaindazole or diazaindazole type as medicament
10/02/2013CN103339128A Azaindoles as respiratory syncytial virus antiviral agents
10/02/2013CN103339126A Pharmaceutical compositions, dosage forms and new forms of the compound of formula (i), and methods of use thereof
1 ... 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 ... 7860